486O - Sequential first-line therapy of metastatic colorectal cancer (mCRC) starting with fluoropyrimidine (FP) plus bevacizumab (BEV) vs. initial FP plus irinotecan (IRI) and BEV: German AIO KRK0110 (ML22011) study

Autor: Modest, D.P., Fischer von Weikersthal, L., Decker, T., Vehling-Kaiser, U., Uhlig, J., Schenk, M., Freiberg-Richter, J., Peuser, B., Denzlinger, C., Peveling Genannt Reddemann, C., Graeven, U., Schuch, G., Schwaner, I., Stahler, A., Jung, A., Held, S., Stintzing, S., Giessen-Jung, C., Heinemann, V.

Publikováno v: In Annals of Oncology September 2017 28 Supplement 5:v164-v164

Sequential Versus Combination Therapy of Metastatic Colorectal Cancer Using Fluoropyrimidines, Irinotecan, and Bevacizumab: A Randomized, Controlled Study-XELAVIRI (AIO KRK0110).

Autor: Modest DP; 1 University Hospital Grosshadern, Munich, Germany.; 2 German Cancer Consortium, Heidelberg, Germany.; 3 German Cancer Research Centre, Heidelberg, Germany., Fischer von Weikersthal L; 4 Gesundheitszentrum St Marien, Amberg, Germany., Decker T; 5 Private Oncological Practice, Ravensburg, Germany., Vehling-Kaiser U; 6 Private Oncological Practice, Landshut, Germany., Uhlig J; 7 Private Oncological Practice, Naunhof, Germany., Schenk M; 8 Krankenhaus Barmherzige Brüder Regensburg, Regensburg, Germany., Freiberg-Richter J; 9 Private Oncological Practice, Dresden, Germany., Peuser B; 10 Onkologische Praxis am Diakonissenhaus, Leipzig, Germany., Denzlinger C; 11 Marienhospital, Stuttgart, Germany., Peveling Genannt Reddemann C; 12 MVZ RNR Leverkusen am Gesundheitspark, Leverkusen, Germany., Graeven U; 13 Kliniken Maria Hilf GmbH, Mönchengladbach, Germany., Schuch G; 14 Hämatologisch-Onkologische Praxis Altona, Hamburg, Germany., Schwaner I; 15 Onkologische Schwerpunktpraxis Kurfürstendamm, Berlin, Germany., Stahler A; 1 University Hospital Grosshadern, Munich, Germany., Jung A; 2 German Cancer Consortium, Heidelberg, Germany.; 3 German Cancer Research Centre, Heidelberg, Germany.; 16 Ludwig Maximilians-Universität, Munich, Germany., Kirchner T; 2 German Cancer Consortium, Heidelberg, Germany.; 3 German Cancer Research Centre, Heidelberg, Germany.; 16 Ludwig Maximilians-Universität, Munich, Germany., Held S; 17 ClinAssess GmbH, Leverkusen, Germany., Stintzing S; 1 University Hospital Grosshadern, Munich, Germany.; 2 German Cancer Consortium, Heidelberg, Germany.; 3 German Cancer Research Centre, Heidelberg, Germany., Giessen-Jung C; 1 University Hospital Grosshadern, Munich, Germany., Heinemann V; 1 University Hospital Grosshadern, Munich, Germany.; 2 German Cancer Consortium, Heidelberg, Germany.; 3 German Cancer Research Centre, Heidelberg, Germany.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2019 Jan 01; Vol. 37 (1), pp. 22-32. Date of Electronic Publication: 2018 Nov 02.